Philipp Kaldis PhD

Philipp Kaldis received his Ph.D. from the Institute for Cell Biology, ETH (Swiss Federal Institute of Technology), Zürich, Switzerland, in 1994 where he worked on the mitochondrial creatine kinase with Dr. Theo Wallimann and Dr. Hans Eppenberger. In 1995, he joined Dr. Mark Solomon’s laboratory at Yale University School of Medicine, Department of Molecular Biophysics and Biochemistry, New Haven, Connecticut, as a postdoctoral fellow/associate research scientist to investigate the activation of cyclin-dependent kinases (Cdks). In 2000, Dr. Kaldis joined the NCI-Frederick as a tenure-track investigator and was promoted to senior investigator with tenure in 2006. From 2007 to 2019, he worked at the Institute of Molecular and Cell Biology (IMCB), Singapore as a senior principal investigator and was an adjunct associate professor at the National University of Singapore (NUS), Department of Biochemistry. In 2019, Dr Kaldis moved to Malmö, Sweden to take up a position at Lund University, Department of Clinical Sciences, at the Clinical Research Centre.